Hypertension in CKD Market Regional Analysis

Regional Analysis

Global Hypertension in CKD Market - Regional Analysis

Among regions, North America is expected to hold a dominant position in the global hypertension in CKD market, owing to the reimbursement policy for chronic kidney diseases in the region. For instance, the Centers for Medicare & Medicaid Services (CMS), a federal agency within the U.S. Department of Health and Human Services, announced the new Medicare model for end-stage renal disease (ESRD), which is also called the last stage of the chronic kidney disease. The model is the End-Stage Renal Disease (ESRD) Treatment Choices (ETC) Model. The model encourages increased use of home dialysis and kidney transplants to help improve the quality of life of Medicare beneficiaries with ESRD. Moreover, this model was implemented on January 1, 2021 and due to the implementation of the model, US$23 Mn was saved over a period of five and a half years.

Furthermore, Europe is also estimated to witness significant growth in the hypertension in CKD market, owing to the increasing prevalence of chronic kidney diseases in the region. For instance, according to an article published in the Lancet Journal in 2022, increasing prevalence of CKD was reported in 2021 in different regions of Europe.

Geographies covered:

North America: U.S. and Canada

Latin America: Brazil, Argentina, Mexico, and Rest of Latin America

Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe

Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific

Middle East: GCC, Israel, and Rest of Middle East

Africa: South Africa, North Africa, and Central Africa

Hypertension in CKD Market Report Snapshots